Botox for Jaw Clenching and a Softer Jawline in Denver

Injecting Botox into the masseter, the thick chewing muscle at the back of your jaw, can soften a square lower face and take some force out of a hard clench. It is also an off-label use of all three neurotoxins Redbud carries, which is ordinary in medicine and worth understanding first.

The question arrives bundled as one promise: slims the face, fixes TMJ, stops grinding, saves your teeth. Four claims, four different bodies of evidence.

Is Botox approved for the jaw?

No. The three products we carry sit on three FDA labels, and a fourth, for therapeutic Botox, matters here because the two Botox labels get mixed up. The masseter is on none of the four.

Botox Cosmetic is FDA-approved in adult patients for temporary improvement in the appearance of four areas, each described on its label as moderate to severe: glabellar lines (frown lines between the brows), lateral canthal lines (crow's feet), forehead lines, and platysma bands (the vertical cords on the neck).

Botox and Botox Cosmetic are two different products with two separate FDA labels. The therapeutic Botox label covers chronic migraine, severe underarm sweating, bladder conditions, spasticity, cervical dystonia, blepharospasm and strabismus. No jaw muscle is on it either.

Dysport is approved for one cosmetic area, moderate to severe glabellar lines, in adults less than 65 years of age. Xeomin is approved in adult patients for the temporary improvement in the appearance of three upper facial lines, each moderate to severe: glabellar, horizontal forehead and lateral canthal. Neither lists the masseter.

So treating the masseter is off label: a licensed prescriber using an approved medication outside its approved indication, guided by clinical judgment and published evidence. That is legal and ordinary across medicine. It does not mean unregulated or experimental, and the drug is FDA-approved and made to the same standard whichever muscle it goes into.

Nor is it unstudied. AbbVie, which makes Botox, has run the masseter through placebo-controlled phase 3 trials of its toxin, onabotulinumtoxinA, with six-month results published in 2026. There is still no approval, but this is past the fringe.

Does it make the jawline look softer?

Yes, and this is the best-evidenced of the four.

A 2026 systematic review pooled five placebo-controlled randomized trials covering 536 people. Toxin beat placebo on masseter prominence at multiple time points, with higher satisfaction. Its authors are cautious: variation between studies was substantial, and there is not yet enough evidence to set an ideal dose.

The phase 3 trial is more concrete. Among 376 participants who all started at the marked or very marked grade, 51.2 percent of those given 72 units improved by at least two grades by day 90, against 2.2 percent on placebo.

In practice that reads as a narrower, less square lower face: the masseter is muscle, so what changes is the soft tissue over your jaw angle. Timing runs slower than a frown line too. Those phase 3 improvements held through day 180, about six months, against the three to four the Botox Cosmetic label gives for frown lines.

Does it stop clenching and grinding?

It reduces the force. Whether it reaches whatever is driving the clench is a different question.

Botulinum toxin blocks the chemical signal that tells a muscle to contract, so the muscle squeezes less hard. Your brain is still sending the signal. Clenching and grinding, which dentists call bruxism, start upstream of the muscle. A weaker muscle does less damage but does not decide to stop.

The published evidence sits in that gap. A 2025 overview of 14 systematic reviews found ten reporting reduced pain, seven fewer bruxism events, five lower bite force. But it graded all 14 critically low or low quality, concluding that prevents a definitive answer.

A 2023 meta-analysis pooling ten studies found toxin beat saline and occlusal splints on bite force and pain at one and three months. By three to six months the difference against saline was gone, and splinting held longer.

The claim about saving your teeth is the thinnest of all. The bruxism studies tracked pain, bruxism events and bite force, not enamel. An earlier phase 2 cosmetic trial did run dental exams and found no clinically relevant changes in the mandible or teeth, which says the treatment did not harm them, not that it protects them. A softer clench is reasonable to hope for, unproven to promise. If enamel is the worry, that belongs with your dentist.

What about TMJ and jaw pain?

It depends which one you mean.

TMJ names a joint. TMD, temporomandibular disorder, names a group of conditions affecting that joint, the muscles that move it, or both. A masseter injection treats muscle. If your problem is the joint itself, a displaced disc, clicking, locking or arthritic change, relaxing a chewing muscle does not address it.

For the muscle kind, two 2024 reviews disagree. An umbrella review of 18 systematic reviews found toxin better than placebo for pain, but no better than standard treatments, no better for jaw movement, and carrying a higher risk of effects on muscle and bone. A review the same year pooled four trials and found toxin no better than placebo at one, three and six months.

If pain is the main complaint, a diagnosis comes before an injection.

What are the risks?

Common effects are small: soreness, bruises, swelling. Two are specific to this muscle. The first is your smile, because the masseter sits near the muscles that lift your mouth corners: in that phase 2 trial, which tested 24 to 96 units, four people at the top dose reported a localized effect on it. The second is chewing: tougher foods can take more effort for a few weeks.

Then there is bone, an open question. A 2022 review of seven studies found five reporting changes to the jaw bone after injection into the chewing muscles, though those studies were small and rated very low quality. Against that, a prespecified subgroup of 123 from that same phase 2 trial had CT scans at baseline, day 90 and day 360 showing no clinically significant change in mandibular bone density. A year of data, not a decade, so repeat treatment over years is not settled.

All botulinum toxin products carry an FDA boxed warning about distant spread of toxin effect, one reason dose and placement belong with a trained injector.

What to expect at Redbud

At Redbud a jaw question starts as a consultation, not a syringe. We look at your lower face at rest and while you clench, and separate the parts: appearance, clenching, pain. Those answers do not always agree, and sometimes the most useful thing we say is that yours is a dental question.

Where masseter injection is a fit, we start conservatively. The muscle is strong and the effect takes time to show, so it is easier to add later than to wait out too much.

Read about Botox Cosmetic, Dysport, Xeomin and our providers. New to neurotoxins? When to start Botox and how long Botox lasts cover the basics, five common myths clears up the worries, and Botox for sweating is the nearest cousin. FAQ page for first visits.

Frequently asked questions

Is Botox for the masseter FDA-approved?

No. The masseter is not on the label of Botox Cosmetic, Botox, Dysport or Xeomin. Treating it is off label, which is legal and ordinary across medicine.

Will masseter Botox slim my whole face?

One muscle only. It can make the lower face read narrower and less square, and does nothing to cheekbones or facial fat.

Can it fix my TMJ?

Not reliably. If the problem sits in the joint itself, a masseter injection does not reach it, and for muscle-based pain the research is split. Get a diagnosis first.

How long does it last on the jaw?

Longer than a frown line. In the phase 3 trial the effect held through day 180, about six months.

Ready to talk about your jaw?

If you clench, wake with a sore jaw, or wish your lower face looked softer, a consultation is the place to sort out which of those we can help with and which belongs elsewhere. Book an appointment at Redbud Medical Spa in Denver and we will walk through it with you.

Medical disclaimer: This article is for general education and is not medical advice. Botox Cosmetic, Dysport and Xeomin are FDA-approved for the cosmetic areas described above and not for the masseter muscle, so treating the masseter is an off-label use. BOTOX and BOTOX Cosmetic are separate products with separate FDA labels. All botulinum toxin products carry a boxed warning about distant spread of toxin effect. Units are specific to each product and are not interchangeable, and nothing here is a dosing guide. Results vary from person to person. Jaw pain, clicking or locking, and tooth wear are medical and dental problems that deserve a diagnosis; whether a neurotoxin has any role in yours is a decision to make with a licensed provider who has examined you.